+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
5851-46-7,MFCD00628961
Catalog No.:AA00EBD6

5851-46-7 | 2-Pentyl-1h-benzimidazole

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$27.00   $19.00
- +
5g
97%
in stock  
$43.00   $30.00
- +
25g
97%
in stock  
$131.00   $92.00
- +
100g
97%
in stock  
$385.00 $269.00
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00EBD6
Chemical Name:
2-Pentyl-1h-benzimidazole
CAS Number:
5851-46-7
Molecular Formula:
C12H16N2
Molecular Weight:
188.2688
MDL Number:
MFCD00628961
SMILES:
CCCCCc1nc2c([nH]1)cccc2
Properties
Computed Properties
 
Complexity:
170  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.6  

Upstream Synthesis Route

[1]SyntheticCommunications,2011,vol.41,#1,p.58-62

[2]TetrahedronLetters,2011,vol.52,#43,p.5575-5580

[3]TetrahedronLetters,2015,vol.56,#48,p.6795-6799

[4]TetrahedronLetters,2007,vol.48,#1,p.61-64

[5]JournalofHeterocyclicChemistry,2010,vol.47,#1,p.153-155

[6]TetrahedronLetters,2010,vol.51,#39,p.5195-5199

[7]RSCAdvances,2016,vol.6,#58,p.53596-53601

[8]Synlett,2004,#10,p.1832-1834

[9]ChineseJournalofChemistry,2010,vol.28,#11,p.2249-2254

[10]CatalysisLetters,2014,vol.144,#12,p.2184-2190

[11]JournalofHeterocyclicChemistry,2008,vol.45,#5,p.1499-1502

[12]ChemistryofHeterocyclicCompounds,2012,vol.48,#7,p.1011-1017

[13]Khim.Geterotsikl.Soedin.,2012,vol.48,#7,p.1088-1094,7

[14]GreenChemistry,2012,vol.14,#12,p.3273-3276

[1]SyntheticCommunications,2007,vol.37,#15,p.2457-2460

[2]Patent:CN103483266,2016,B,.Locationinpatent:Paragraph0041;0042;0043;0044

[3]AnnalesPharmaceutiquesFrancaises,2003,vol.61,#1,p.57-61

[4]SyntheticCommunications,2002,vol.32,#24,p.3703-3709

[5]NewJournalofChemistry,2007,vol.31,#8,p.1417-1420

[6]JournaloftheChemicalSociety,1937,p.1699

[7]MonatsheftefuerChemie,1931,vol.57,p.97,104

[8]JournaloftheAmericanChemicalSociety,1937,vol.59,p.178

[1]BulletinoftheKoreanChemicalSociety,2012,vol.33,#12,p.4188-4190

[1]BulletinoftheKoreanChemicalSociety,2012,vol.33,#12,p.4188-4190

[1]ACSCatalysis,2017,vol.7,#11,p.7456-7460

[2]ChemCatChem,2018,vol.10,#7,p.1607-1613

[3]Chemistry-AEuropeanJournal,2014,vol.20,#19,p.5569-5572

[4]DaltonTransactions,2017,vol.46,#43,p.15012-15022

[5]OrganicPreparationsandProceduresInternational,2008,vol.40,#1,p.101-105

[6]ChemischeBerichte,1936,vol.69,p.2263,2270

Downstream Synthesis Route

[1]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1958,vol.78,p.242    Japan.J.med.Sci.Biol.,1957,vol.10,p.455,456

[1]JournalofOrganicChemistry,1944,vol.9,p.31,33,42

[1]SyntheticCommunications,2007,vol.37,p.2457-2460

[2]Patent:CN103483266,2016,B.Locationinpatent:Paragraph0041;0042;0043;0044

[3]AnnalesPharmaceutiquesFrancaises,2003,vol.61,p.57-61

[4]SyntheticCommunications,2002,vol.32,p.3703-3709

[5]NewJournalofChemistry,2007,vol.31,p.1417-1420

[6]JournaloftheChemicalSociety,1937,p.1699

[7]Patent:US2019/144395,2019,A1.Locationinpatent:Paragraph0157;0158

[8]OrganicandBiomolecularChemistry,2021,vol.19,p.8133-8139

[1]ACSCatalysis,2017,vol.7,p.7456-7460

[2]ChemCatChem,2018,vol.10,p.1607-1613

[3]Chemistry-AEuropeanJournal,2014,vol.20,p.5569-5572

[4]DaltonTransactions,2017,vol.46,p.15012-15022

[5]Catalysisscienceandtechnology,2020,vol.10,p.6495-6500

[6]InorganicChemistry,2021,vol.60,p.16042-16047

[7]OrganicPreparationsandProceduresInternational,2008,vol.40,p.101-105

[8]ChemicalCommunications,2019,vol.55,p.5958-5961

[9]GreenChemistry,2019,vol.21,p.1999-2004

[10]ChemischeBerichte,1936,vol.69,p.2263,2270

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 5851-46-7
14678-78-5

14678-78-5

 5851-43-4

5851-43-4

 5851-50-3

5851-50-3

 5465-29-2

5465-29-2

 2403-66-9

2403-66-9

 16405-79-1

16405-79-1
Building Blocks
More >
Historical Records
126689-77-8

126689-77-8
Tags:5851-46-7 Molecular Formula|5851-46-7 MDL|5851-46-7 SMILES|5851-46-7 2-Pentyl-1h-benzimidazole
Catalog No.: AA00EBD6
5851-46-7,MFCD00628961
5851-46-7 | 2-Pentyl-1h-benzimidazole
Pack Size： 1g
Purity： 97%
in stock
$27.00 $19.00
Pack Size： 5g
Purity： 97%
in stock
$43.00 $30.00
Pack Size： 25g
Purity： 97%
in stock
$131.00 $92.00
Pack Size： 100g
Purity： 97%
in stock
$385.00 $269.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00EBD6
Chemical Name: 2-Pentyl-1h-benzimidazole
CAS Number: 5851-46-7
Molecular Formula: C12H16N2
Molecular Weight: 188.2688
MDL Number: MFCD00628961
SMILES: CCCCCc1nc2c([nH]1)cccc2
Properties
Complexity: 170  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 14  
Hydrogen Bond Acceptor Count: 1  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 4  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.6  
Upstream Synthesis Route
66-25-1    95-54-5    5851-46-7 

[1]SyntheticCommunications,2011,vol.41,#1,p.58-62

[2]TetrahedronLetters,2011,vol.52,#43,p.5575-5580

[3]TetrahedronLetters,2015,vol.56,#48,p.6795-6799

[4]TetrahedronLetters,2007,vol.48,#1,p.61-64

[5]JournalofHeterocyclicChemistry,2010,vol.47,#1,p.153-155

[6]TetrahedronLetters,2010,vol.51,#39,p.5195-5199

[7]RSCAdvances,2016,vol.6,#58,p.53596-53601

[8]Synlett,2004,#10,p.1832-1834

[9]ChineseJournalofChemistry,2010,vol.28,#11,p.2249-2254

[10]CatalysisLetters,2014,vol.144,#12,p.2184-2190

[11]JournalofHeterocyclicChemistry,2008,vol.45,#5,p.1499-1502

[12]ChemistryofHeterocyclicCompounds,2012,vol.48,#7,p.1011-1017

[13]Khim.Geterotsikl.Soedin.,2012,vol.48,#7,p.1088-1094,7

[14]GreenChemistry,2012,vol.14,#12,p.3273-3276

95-54-5    142-62-1    5851-46-7 

[1]SyntheticCommunications,2007,vol.37,#15,p.2457-2460

[2]Patent:CN103483266,2016,B,.Locationinpatent:Paragraph0041;0042;0043;0044

[3]AnnalesPharmaceutiquesFrancaises,2003,vol.61,#1,p.57-61

[4]SyntheticCommunications,2002,vol.32,#24,p.3703-3709

[5]NewJournalofChemistry,2007,vol.31,#8,p.1417-1420

[6]JournaloftheChemicalSociety,1937,p.1699

[7]MonatsheftefuerChemie,1931,vol.57,p.97,104

[8]JournaloftheAmericanChemicalSociety,1937,vol.59,p.178

102-86-3    95-54-5    5851-46-7 

[1]BulletinoftheKoreanChemicalSociety,2012,vol.33,#12,p.4188-4190

143-16-8    95-54-5    5851-46-7 

[1]BulletinoftheKoreanChemicalSociety,2012,vol.33,#12,p.4188-4190

95-54-5    111-27-3    5851-46-7 

[1]ACSCatalysis,2017,vol.7,#11,p.7456-7460

[2]ChemCatChem,2018,vol.10,#7,p.1607-1613

[3]Chemistry-AEuropeanJournal,2014,vol.20,#19,p.5569-5572

[4]DaltonTransactions,2017,vol.46,#43,p.15012-15022

[5]OrganicPreparationsandProceduresInternational,2008,vol.40,#1,p.101-105

[6]ChemischeBerichte,1936,vol.69,p.2263,2270

Downstream Synthesis Route
5851-46-7    28742-68-9 

[1]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1958,vol.78,p.242    Japan.J.med.Sci.Biol.,1957,vol.10,p.455,456

628-73-9    95-54-5    5851-46-7 

[1]JournalofOrganicChemistry,1944,vol.9,p.31,33,42

95-54-5    142-62-1    5851-46-7 

[1]SyntheticCommunications,2007,vol.37,p.2457-2460

[2]Patent:CN103483266,2016,B.Locationinpatent:Paragraph0041;0042;0043;0044

[3]AnnalesPharmaceutiquesFrancaises,2003,vol.61,p.57-61

[4]SyntheticCommunications,2002,vol.32,p.3703-3709

[5]NewJournalofChemistry,2007,vol.31,p.1417-1420

[6]JournaloftheChemicalSociety,1937,p.1699

[7]Patent:US2019/144395,2019,A1.Locationinpatent:Paragraph0157;0158

[8]OrganicandBiomolecularChemistry,2021,vol.19,p.8133-8139

95-54-5    111-27-3    5851-46-7 

[1]ACSCatalysis,2017,vol.7,p.7456-7460

[2]ChemCatChem,2018,vol.10,p.1607-1613

[3]Chemistry-AEuropeanJournal,2014,vol.20,p.5569-5572

[4]DaltonTransactions,2017,vol.46,p.15012-15022

[5]Catalysisscienceandtechnology,2020,vol.10,p.6495-6500

[6]InorganicChemistry,2021,vol.60,p.16042-16047

[7]OrganicPreparationsandProceduresInternational,2008,vol.40,p.101-105

[8]ChemicalCommunications,2019,vol.55,p.5958-5961

[9]GreenChemistry,2019,vol.21,p.1999-2004

[10]ChemischeBerichte,1936,vol.69,p.2263,2270

Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Related Products of of 5851-46-7
14678-78-5
14678-78-5
5851-43-4
5851-43-4
5851-50-3
5851-50-3
5465-29-2
5465-29-2
2403-66-9
2403-66-9
16405-79-1
16405-79-1
Building Blocks More >
64192-56-9
64192-56-9
azo analog I
AA00EBJ9 | MFCD00216070
60611-22-5
60611-22-5
2-Chloro-6-(trifluoromethyl)benzaldehyde
AA00EBNC | MFCD06660231
62071-40-3
62071-40-3
4-(Oxan-4-yl)aniline
AA00EBV1 | MFCD11506022
59820-91-6
59820-91-6
7-Bromo-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxylic acid
AA00EC02 | MFCD00510294
594-83-2
594-83-2
2,3,3-Trimethyl 2-butanol
AA00EC5X | MFCD00060887
63550-99-2
63550-99-2
Rebaudioside c
AA00ECBR | MFCD30188121
565191-92-6
565191-92-6
3-(4-Benzyl-3-oxo-7-(trifluoromethyl)-3,4-dihydroquinoxalin-2-yl)propanoic acid
AA00ECFX | MFCD03964648
6342-63-8
6342-63-8
3-Acetyl-4-bromoanisole
AA00ECLL | MFCD02683853
59830-60-3
59830-60-3
Cbz-l-phenylalaninal
AA00ECRU | MFCD00798796
595610-40-5
595610-40-5
Ethyl 5-(4-chlorophenyl)-2H-pyrazole-3-carboxylate
AA00ED0H | MFCD03130040
Historical Records
126689-77-8
126689-77-8
Submit
© 2017 AA BLOCKS, INC. All rights reserved.